Market Place
Sourcing Support
All News #Library
Quality
FDA Warns Indian Drugmaker for Quality Lapses, Enrollment Issues
09 Sep 2025 //
RAPS
Hikal spurts after Gujarat facilty gets EIR from USFDA
12 Dec 2019 //
BUSINESS-STANDARD
EIR Report Received from the USFDA Inspection of Pharma Facility at Panoli
20 Mar 2019 //
PRESS RELEASE
Inspection at Jigani, Banglore by PMDA
17 Aug 2018 //
PRESS RELEASE
Hikal soars as USFDA issues `Zero` 483 observations for Bangalore facility
10 Jan 2016 //
BUSINESS STANDARD
Indian pharma`s struggle to tighten standards paves way for M&A deals | Reuters
29 Jun 2015 //
DRUG REGULATIONS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.